These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8399654)

  • 1. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myoglobin elimination in end stage kidney disease patients on renal replacement treatment.
    Stefanović V; Bogićević M; Mitić M
    Int J Artif Organs; 1993 Sep; 16(9):659-61. PubMed ID: 8294158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S; Kraus AP; Jennings BR
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2 microglobulin in CAPD.
    Montenegro J; Martínez I; Saracho R; González R
    Adv Perit Dial; 1992; 8():369-72. PubMed ID: 1361825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Catizone L; Cocchi R; Fusaroli M; Zucchelli P
    Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean?
    Canaud B; Assounga A; Flavier JL; Slingeneyer A; Aznar R; Robinet-Levy M; Mion C
    ASAIO Trans; 1988; 34(4):923-9. PubMed ID: 3064791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of beta 2-microglobulin in patients undergoing blood purification].
    Hou FF
    Zhonghua Nei Ke Za Zhi; 1990 Jun; 29(6):353-6, 383. PubMed ID: 2269036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
    Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta-2-microglobulin level and residual renal function in peritoneal dialysis.
    Amici G; Virga G; Da Rin G; Grandesso S; Vianello A; Gatti P; Bocci C
    Nephron; 1993; 65(3):469-71. PubMed ID: 8290003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
    Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
    Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients.
    Vincent C; Chanard J; Caudwell V; Lavaud S; Wong T; Revillard JP
    Kidney Int; 1992 Dec; 42(6):1434-43. PubMed ID: 1474777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of beta 2-microglobulin and albumin in plasma and peritoneal dialysis fluid by a noncompetitive immunoenzymometric assay.
    Kandoussi A; Cachera C; Pagniez D; Saile R; Tacquet A
    Clin Chem; 1993 Jan; 39(1):93-6. PubMed ID: 8419067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of beta 2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum.
    Niwa T; Katsuzaki T; Momoi T; Miyazaki T; Ogawa H; Saito A; Miyazaki S; Maeda K; Tatemichi N; Takei Y
    Kidney Int; 1996 Mar; 49(3):861-7. PubMed ID: 8648931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular variants of beta 2-microglobulin in renal insufficiency.
    Vincent C; Dennoroy L; Revillard JP
    Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):181-7. PubMed ID: 8129718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating form of beta-2-microglobulin in dialysis patients.
    Gagnon RF; Somerville P; Thomson DM
    Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
    Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
    Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis.
    Piraino B; Bender F; Bernardini J
    Perit Dial Int; 1994; 14(2):145-8. PubMed ID: 8043667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition and removal of cutaneous beta 2-microglobulin.
    Spiegel DM; Costante N; Janiga AM; Haas M; Soltani K
    Am J Nephrol; 1992; 12(5):330-5. PubMed ID: 1489002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.